• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于机制的 NADPH 氧化酶(Ⅱ型)抑制剂对 LPS 诱导的急性肺损伤的保护作用。

Protection against LPS-induced acute lung injury by a mechanism-based inhibitor of NADPH oxidase (type 2).

机构信息

Institute for Environmental Medicine, Univ. of Pennsylvania, 3620 Hamilton Walk, 1 John Morgan Bldg., Philadelphia, PA 19104.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2014 Apr 1;306(7):L635-44. doi: 10.1152/ajplung.00374.2013. Epub 2014 Jan 31.

DOI:10.1152/ajplung.00374.2013
PMID:24487388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3962626/
Abstract

The phospholipase A2 activity of peroxiredoxin 6 is inhibited by the transition state analog, 1-hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol (MJ33). This activity is required for the activation of NADPH oxidase, type 2. The present study evaluated the effect of MJ33 on manifestations of acute lung injury. Mice were injected intratracheally (IT) with LPS from Escherichia coli 0111:B4 (LPS, 1 or 5 mg/kg), either concurrently with LPS or 2 h later, and evaluated for lung injury 24 h later. MJ33 inhibited reactive oxygen species (ROS) generation by lungs when measured at 24 h after LPS. LPS at either a low or high dose significantly increased lung infiltration with inflammatory cells, secretion of proinflammatory cytokines (IL-6, TNF-α, and the chemokine macrophage inflammatory protein-2), expression of lung vascular cell adhesion molecule, lung permeability (protein in bronchoalveolar lavage fluid, leakage of FITC-dextran, lung wet-to-dry weight ratio), tissue lipid peroxidation (thiobarbituric acid reactive substances, 8-isoprostanes), tissue protein oxidation (protein carbonyls), and activation of NF-κB. MJ33, given either concurrently or 2 h subsequent to LPS, significantly reduced all of these measured parameters. Previous studies of toxicity showed a high margin of safety for MJ33 in the intact mouse. Thus we have identified MJ33 as a potent, nontoxic, and specific mechanism-based inhibitor of NADPH oxidase type 2-mediated ROS generation that protects mice against lung injury associated with inflammation.

摘要

过氧化物酶 6 的磷酸脂酶 A2 活性被过渡态类似物 1-十六烷基-3-(三氟乙基)-sn-甘油-2-磷酸甲醇(MJ33)抑制。这种活性对于 NADPH 氧化酶 2 型的激活是必需的。本研究评估了 MJ33 对急性肺损伤表现的影响。小鼠通过气管内注射大肠杆菌 0111:B4 的脂多糖(LPS,1 或 5mg/kg),与 LPS 同时或 2 小时后注射,并在 24 小时后评估肺损伤。MJ33 抑制了 LPS 24 小时后肺部活性氧(ROS)的生成。低剂量或高剂量 LPS 均显著增加了肺部炎症细胞浸润、促炎细胞因子(IL-6、TNF-α 和趋化因子巨噬细胞炎症蛋白-2)的分泌、肺血管细胞黏附分子的表达、肺通透性(支气管肺泡灌洗液中的蛋白、FITC-右旋糖酐的泄漏、肺湿重/干重比)、组织脂质过氧化(硫代巴比妥酸反应物质、8-异前列腺素)、组织蛋白氧化(蛋白羰基)和 NF-κB 的激活。MJ33 与 LPS 同时或 2 小时后给予,显著降低了所有这些测量参数。先前的毒性研究表明,在完整的小鼠中,MJ33 具有很高的安全性。因此,我们已经确定 MJ33 是一种有效的、非毒性的、特异性的 NADPH 氧化酶 2 型介导的 ROS 生成的机制基础抑制剂,可保护小鼠免受与炎症相关的肺损伤。

相似文献

1
Protection against LPS-induced acute lung injury by a mechanism-based inhibitor of NADPH oxidase (type 2).一种基于机制的 NADPH 氧化酶(Ⅱ型)抑制剂对 LPS 诱导的急性肺损伤的保护作用。
Am J Physiol Lung Cell Mol Physiol. 2014 Apr 1;306(7):L635-44. doi: 10.1152/ajplung.00374.2013. Epub 2014 Jan 31.
2
A novel nontoxic inhibitor of the activation of NADPH oxidase reduces reactive oxygen species production in mouse lung.一种新型无毒 NADPH 氧化酶激活抑制剂可减少小鼠肺内活性氧的产生。
J Pharmacol Exp Ther. 2013 May;345(2):284-96. doi: 10.1124/jpet.112.201079. Epub 2013 Mar 8.
3
Inhibition of the phospholipase A2 activity of peroxiredoxin 6 prevents lung damage with exposure to hyperoxia.抑制过氧化物氧还蛋白6的磷脂酶A2活性可防止暴露于高氧环境时的肺损伤。
Redox Biol. 2015;4:321-7. doi: 10.1016/j.redox.2015.01.011. Epub 2015 Jan 16.
4
Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.PECAM 靶向递送至体外和体内内皮细胞新型 NADPH 氧化酶抑制剂的抗氧化保护作用。
J Control Release. 2012 Oct 28;163(2):161-9. doi: 10.1016/j.jconrel.2012.08.031. Epub 2012 Sep 6.
5
Genetic inactivation of the phospholipase A activity of peroxiredoxin 6 in mice protects against LPS-induced acute lung injury.基因敲除过氧化物酶 6 的磷脂酶 A 活性可保护小鼠免受脂多糖诱导的急性肺损伤。
Am J Physiol Lung Cell Mol Physiol. 2019 Apr 1;316(4):L656-L668. doi: 10.1152/ajplung.00344.2018. Epub 2019 Jan 31.
6
A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS).一种 NADPH 氧化酶(NOX2)激活的肽抑制剂显著降低了给予脂多糖(LPS)后小鼠的肺损伤和死亡率。
Int J Mol Sci. 2019 May 15;20(10):2395. doi: 10.3390/ijms20102395.
7
Protective effects of diphenyleneiodonium, an NADPH oxidase inhibitor, on lipopolysaccharide-induced acute lung injury.二苯乙烯碘鎓,一种 NADPH 氧化酶抑制剂,对脂多糖诱导的急性肺损伤的保护作用。
Clin Exp Pharmacol Physiol. 2019 Feb;46(2):153-162. doi: 10.1111/1440-1681.13050. Epub 2018 Nov 22.
8
NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-κB activity.NADPH 氧化酶通过调节 NF-κB 活性的氧化还原反应限制脂多糖诱导的小鼠肺炎症和损伤。
J Immunol. 2013 May 1;190(9):4786-94. doi: 10.4049/jimmunol.1201809. Epub 2013 Mar 25.
9
Mediators released from LPS-challenged lungs induce inflammatory responses in liver vascular endothelial cells and neutrophilic leukocytes.来自脂多糖刺激的肺部释放的介质可诱导肝血管内皮细胞和中性粒细胞产生炎症反应。
Am J Physiol Gastrointest Liver Physiol. 2009 Dec;297(6):G1066-76. doi: 10.1152/ajpgi.00278.2009. Epub 2009 Oct 8.
10
Picrasma quassiodes (D. Don) Benn. attenuates lipopolysaccharide (LPS)-induced acute lung injury.苦木(Picrasma quassiodes (D. Don) Benn.)可减轻脂多糖(LPS)诱导的急性肺损伤。
Int J Mol Med. 2016 Sep;38(3):834-44. doi: 10.3892/ijmm.2016.2669. Epub 2016 Jul 7.

引用本文的文献

1
Effect of Acute Lung Injury (ALI) Induced by Lipopolysaccharide (LPS) on the Pulmonary Pharmacokinetics of an Antibody.脂多糖(LPS)诱导的急性肺损伤(ALI)对一种抗体肺部药代动力学的影响
Antibodies (Basel). 2025 Apr 6;14(2):33. doi: 10.3390/antib14020033.
2
Dose-dependent multi-organ injury following lipopolysaccharide gas inhalation.脂多糖气体吸入致剂量依赖性多器官损伤。
J Int Med Res. 2024 May;52(5):3000605241247707. doi: 10.1177/03000605241247707.
3
Decreased LPS-induced lung injury in pigs treated with a lung surfactant protein A-derived nonapeptide that inhibits peroxiredoxin 6 activity and subsequent NOX1,2 activation.肺表面活性蛋白 A 衍生的九肽抑制过氧化物酶 6 活性及随后的 NOX1、2 激活,可减轻脂多糖诱导的猪肺损伤。
Am J Physiol Lung Cell Mol Physiol. 2024 Apr 1;326(4):L458-L467. doi: 10.1152/ajplung.00325.2023. Epub 2024 Feb 13.
4
Oxidative Stress and Inflammation in Acute and Chronic Lung Injuries.急性和慢性肺损伤中的氧化应激与炎症
Antioxidants (Basel). 2023 Feb 21;12(3):548. doi: 10.3390/antiox12030548.
5
Deuterated Arachidonic Acid Ameliorates Lipopolysaccharide-Induced Lung Damage in Mice.氘代花生四烯酸改善脂多糖诱导的小鼠肺损伤。
Antioxidants (Basel). 2022 Mar 31;11(4):681. doi: 10.3390/antiox11040681.
6
Inhibition of Peroxiredoxin 6 PLA2 Activity Decreases Oxidative Stress and the Severity of Acute Lung Injury in the Mouse Cecal Ligation and Puncture Model.抑制过氧化物酶体增殖物激活受体6磷脂酶A2活性可降低小鼠盲肠结扎和穿刺模型中的氧化应激及急性肺损伤的严重程度。
Antioxidants (Basel). 2021 Oct 24;10(11):1676. doi: 10.3390/antiox10111676.
7
A Peptide Inhibitor of Peroxiredoxin 6 Phospholipase A Activity Significantly Protects against Lung Injury in a Mouse Model of Ventilator Induced Lung Injury (VILI).一种过氧化物还原酶6磷脂酶A活性的肽抑制剂在呼吸机诱导性肺损伤(VILI)小鼠模型中显著保护肺免受损伤。
Antioxidants (Basel). 2021 Jun 7;10(6):925. doi: 10.3390/antiox10060925.
8
Ischemia-Reperfusion Injury in Lung Transplantation.肺移植中的缺血再灌注损伤。
Cells. 2021 May 28;10(6):1333. doi: 10.3390/cells10061333.
9
Short-Term versus Long-Term Culture of A549 Cells for Evaluating the Effects of Lipopolysaccharide on Oxidative Stress, Surfactant Proteins and Cathelicidin LL-37.短期与长期培养 A549 细胞评估脂多糖对氧化应激、表面活性蛋白和抗菌肽 LL-37 的影响
Int J Mol Sci. 2020 Feb 9;21(3):1148. doi: 10.3390/ijms21031148.
10
Lipoxin A4 Ameliorates Acute Pancreatitis-Associated Acute Lung Injury through the Antioxidative and Anti-Inflammatory Effects of the Nrf2 Pathway.脂氧素 A4 通过 Nrf2 通路的抗氧化和抗炎作用改善急性胰腺炎相关急性肺损伤。
Oxid Med Cell Longev. 2019 Nov 6;2019:2197017. doi: 10.1155/2019/2197017. eCollection 2019.

本文引用的文献

1
NOX2 in lung inflammation: quantum dot based in situ imaging of NOX2-mediated expression of vascular cell adhesion molecule-1.NOX2 在肺部炎症中的作用:基于量子点的原位成像技术观察 NOX2 介导的血管细胞黏附分子-1 的表达。
Am J Physiol Lung Cell Mol Physiol. 2014 Feb;306(3):L260-8. doi: 10.1152/ajplung.00278.2013. Epub 2013 Dec 6.
2
Evaluation of recombinant activated protein C for severe sepsis at a tertiary academic medical center.在一家三级学术医学中心评估重组活化蛋白 C 治疗严重脓毒症。
Ther Clin Risk Manag. 2013;9:277-84. doi: 10.2147/TCRM.S45412. Epub 2013 Jun 5.
3
A novel nontoxic inhibitor of the activation of NADPH oxidase reduces reactive oxygen species production in mouse lung.一种新型无毒 NADPH 氧化酶激活抑制剂可减少小鼠肺内活性氧的产生。
J Pharmacol Exp Ther. 2013 May;345(2):284-96. doi: 10.1124/jpet.112.201079. Epub 2013 Mar 8.
4
Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammation.阻断 NOX2 和 STIM1 信号通路可限制脂多糖诱导的血管炎症。
J Clin Invest. 2013 Feb;123(2):887-902. doi: 10.1172/JCI65647. Epub 2013 Jan 25.
5
Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells.TLR4/NADPH 氧化酶/ROS 激活的 p38MAPK 在脂多糖诱导的人肾小球系膜细胞 VCAM-1 表达中的作用。
Cell Commun Signal. 2012 Nov 15;10(1):33. doi: 10.1186/1478-811X-10-33.
6
Oxidative stress contributes to lung injury and barrier dysfunction via microtubule destabilization.氧化应激通过微管去稳定化导致肺损伤和屏障功能障碍。
Am J Respir Cell Mol Biol. 2012 Nov;47(5):688-97. doi: 10.1165/rcmb.2012-0161OC. Epub 2012 Jul 27.
7
Septic shock--evaluating another failed treatment.脓毒性休克——评估又一种失败的治疗方法。
N Engl J Med. 2012 May 31;366(22):2122-4. doi: 10.1056/NEJMe1203412. Epub 2012 May 22.
8
NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS.NADPH 氧化酶抑制剂:从 Nox2ds 到高通量筛选的十年发现。
Cell Mol Life Sci. 2012 Jul;69(14):2315-25. doi: 10.1007/s00018-012-1009-2. Epub 2012 May 15.
9
Neutrophils augment LPS-mediated pro-inflammatory signaling in human lung epithelial cells.中性粒细胞增强人肺上皮细胞中脂多糖介导的促炎信号传导。
Biochim Biophys Acta. 2012 Jul;1823(7):1151-62. doi: 10.1016/j.bbamcr.2012.04.012. Epub 2012 May 1.
10
Stakeholder involvement in expensive drug recommendation decisions: an international perspective.利益相关者参与昂贵药物推荐决策:国际视角。
Health Policy. 2012 May;105(2-3):226-35. doi: 10.1016/j.healthpol.2011.12.002. Epub 2012 Jan 5.